Final results of a University of Chicago phase II consortium trial of sorafenib (SOR) in patients (pts) with imatinib (IM)- and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST) Meeting Abstract
| Authors: | Campbell, N. P.; Wroblewski, K.; Maki, R. G.; D'Adamo, D. R.; Chow, W. A.; Gandara, D. R.; Antonescu, C.; Stadler, W. M.; Vokes, E. E.; Kindler, H. L. |
| Abstract Title: | Final results of a University of Chicago phase II consortium trial of sorafenib (SOR) in patients (pts) with imatinib (IM)- and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST) |
| Meeting Title: | 2011 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2011 Jan 20-22 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-02-01 |
| Language: | English |
| ACCESSION: | WOS:000208847100005 |
| DOI: | 10.1200/jco.2011.29.4_suppl.4 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4 -- Source: Wos |
Altmetric
Citation Impact
